Google’s life sciences division Verily is to play a part in an observational Parkinson’s disease study. The company is to work with Radboud University Medical Center, ...

Google's Verily is pivoting, again. Its chronic disease management app Onduo will transition to a new, “evolved” product called Lightpath.

Verily, I swear. Google Life Sciences debuts a new name. By Charles Piller Dec. 7, 2015. Reprints. Google Life Sciences announced that it now will be known as Verily. Virginia Mayo/AP.

Verily, Alphabet's life sciences subsidiary, has set a deadline of December 16 to sever multiple ties to Google, according to two people familiar with the matter and internal documents reviewed by ...

Trump announced Google was building a virus screening tool. Then someone had to build it. How a presidential promise launched Verily, an Alphabet-owned health science unit, to the front lines of ...

Google and Verily clarify their roles in the US coronavirus response [UPDATED 3/15] The portal, developed by a different Alphabet company, is not ready for national use.

“Verily is a smaller Alphabet company, and it's structured and scaled very differently.” Spokespeople from the rest of Alphabet’s Other Bets, as well as a spokesperson from Google, didn’t ...

The post Google’s Verily healthcare project more hype than hope: report appeared first on SiliconBeat. Originally Published: June 7, 2016 at 5:07 AM PDT. Share this: ...

Now that the Verily and Google sites are live, it’s more clear than ever that the website Trump described is not what the American public will use to find coronavirus testing.

Verily, the life sciences division of Google, is experiencing a leadership exodus, with at least 12 managers, scientists and engineers leaving the company within one year, finds STAT.

Alphabet’s Verily, née Google Life Sciences, is birthing a brand-new company.. It’s called Verb Surgical, a collaboration with Johnson & Johnson, and it aims to make robots better surgical ...

Google and Verily, Alphabet's life sciences arm, are using machine learning to screen for diabetic retinopathy (DR) and diabetic macular edema (DME), two eye conditions that can lead to blindness.